Wikio - Millennium Pharmaceuticals

FDA Approves VELCADE(R) (Bortezomib) for Injection for Patients With Previously Untreated Multiple Myeloma (Red Orbit )

Sat, 21 Jun 2008 02:00:05 GMT

CAMBRIDGE, Mass. and OSAKA, Japan, June 20 /PRNewswire/ -- Millennium Pharmaceuticals, The Takeda Oncology Company, and Takeda Pharmaceutical Company Limited ("Takeda", TSE: 4502) today announced that the U.S.

Source : Red Orbit (subscribe)

Explore : Drug Manufacturers, Health, Japan, Osaka

Multiple Clinical Trials of VELCADE(R) (Bortezomib) for Injection Based Therapies Demonstrate High Complete Remission Rates in Patients with Newly Diagnosed Multiple Myeloma (The Earth Times Online Newspaper)

Sat, 31 May 2008 21:37:27 GMT

CHICAGO, May 31 /PRNewswire/ -- Millennium Pharmaceuticals, The Takeda Oncology Company, today announced the presentation of results from three clinical trials of VELCADE based therapies that showed consistently high complete remission(1) (CR) rates in patien...

Source : The Earth Times Online Newspaper (subscribe)

VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma (Red Orbit )

Sat, 31 May 2008 17:00:06 GMT

CHICAGO, May 31 /PRNewswire/ -- Millennium Pharmaceuticals, The Takeda Oncology Company, today announced the presentation of updated results from a 482 patient, multi-center, randomized Phase III clinical trial, comparing VELCADE and dexamethasone (VcD) to vincristine, adriamycin and dexamethasone (VAD).

Source : Red Orbit (subscribe)

Explore : Health

Biotech ETFs Could Get A Shot In The Arm From Acquisition (ETF Trends)

Sat, 10 May 2008 08:00:00 GMT

Biotechnology is rising up to analyst's predictions that a near future run could send related stocks and exchange traded funds (ETFs) up. The latest April announcement that Takeda Pharmaceutical would buy Massachusetts-based Millennium Pharmaceuticals (MLMN) for $8.8 billion sent the...

Source : ETF Trends (subscribe)

Explore : Biotechnology, Drug Manufacturers, Massachusetts

MBF Financial: New Analyst Reports for GILEAD SCIENCES INC, ISIS PHARMACEUTICALS INC, CURIS INC, and MILLENNIUM PHARMACEUTICALS INC (Market Wire - Investment Opinion)

Fri, 09 May 2008 18:05:00 GMT

LONDON (MARKET WIRE)

Source : Market Wire - Investment Opinion (subscribe)

Explore : Technology

Will M&A Activity Boost PowerShares Dynamic Biotech & Genome ETF? (Seeking Alpha)

Fri, 09 May 2008 12:02:38 GMT

Don Dion submits: The April announcement that Japanese drug maker Takeda Pharmaceutical would buy Massachusetts-based Millennium Pharmaceuticals (MLNM) (which sells the anticancer injection Velcade) for $8.8 billion sent Millennium shares markedly higher. The acquisition also lifted expectations for a run of biotech M&A, boosting much of the sector. Complete Story »

Source : Seeking Alpha (subscribe)

Explore : China, Massachusetts

Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period (The Earth Times Online Newspaper)

Fri, 09 May 2008 06:21:51 GMT

OSAKA, Japan, and CAMBRIDGE, Mass., May 9 /PRNewswire-FirstCall/ -- Takeda Pharmaceutical Company Limited, Takeda , and Millennium Pharmaceuticals, Inc., Millennium today announced the succe...

Source : The Earth Times Online Newspaper (subscribe)

Explore : Japan, Osaka

Takeda sees big profit slump on Millennium costs (The Earth Times Online Newspaper)

Fri, 09 May 2008 05:23:06 GMT

TOKYO (Reuters) - Japan's Takeda Pharmaceutical Co Ltd posted a 7.7 percent fall in annual operating profit on Friday and forecast a sharp drop for the current year on costs for its $8.8 billion purchase of U.S. biotech firm Millennium Pharmaceuticals.

Source : The Earth Times Online Newspaper (subscribe)

Explore : Business, Drug Manufacturers, Japan, Tokyo

Takeda sees big profit slump on Millennium costs (Reuters)

Fri, 09 May 2008 05:21:36 GMT

Source : Reuters (subscribe)

Explore : Business, Japan, Tokyo

Wall Street News Alert: Wall Street News Alert Issues Special Alert on OCOL! May 6, 2008 (Market Wire - Investment Opinion)

Tue, 06 May 2008 12:43:00 GMT

WESTON, FL (MARKET WIRE) Wall Street News Alert's "stocks to watch" this morning are: Oncolin Therapeutics (OTCBB: OCOL), Vanda Pharmaceuticals Inc. (NASDAQ: VNDA), Millennium Pharmaceuticals, Inc. (NASDAQ: MLNM), Gilead Sciences, Inc. (NASDAQ: GILD).

Source : Market Wire - Investment Opinion (subscribe)

Explore : NASDAQ

Abbott's First Quarter Lobbying Tab Hits $880,000 (Patent Docs)

Sat, 03 May 2008 04:50:44 GMT

By Donald Zuhn -- In March, we reported on the lobbying expenditures for a number of biotech and pharmaceutical companies in 2007. For example, we noted that Millennium Pharmaceuticals had spent $1.28 million, Genentech $1.8 million, and AstraZeneca $4.1 million in 2007. Topping each of these companies, however, was Abbott...

Source : Patent Docs (subscribe)

Explore : AstraZeneca, Biotechnologies, Genentech

Regulators in two continents clear Millennium sale (The Boston Business Journal)

Tue, 29 Apr 2008 14:49:57 GMT

Government regulators in the United States, Austria and Germany have cleared the planned $8.8 billion sale of Millennium Pharmaceuticals Inc. to Japanese drug maker Takeda Pharmaceutical Co. Ltd.

Source : The Boston Business Journal (subscribe)

Explore : Business, Government

Millennium's Levin uses golden touch to fund start-up (Fiercebiotech)

Tue, 29 Apr 2008 10:59:57 GMT

Mark Levin earned a reputation for a colorful personality with an incredible knack for raising cash as co-founder of Millennium Pharmaceuticals. Two weeks ago, Takeda helped seal Levin's reputation Read more...

Source : Fiercebiotech (subscribe)

Explore : Cities and Towns, Golden, INCredible, Record Labels

U.S. Deal May Take Time to Help Takeda (Law Blog - WSJ.com)

Thu, 24 Apr 2008 18:56:00 GMT

Takeda's bid to buy Millennium Pharmaceuticals could weigh on profits and share prices in the short term. Still, analysts say the acquisition, which gives Takeda a foothold in the lucrative cancer-drug market and bolsters its pipeline, may be good news for investors in the long run.

Source : Law Blog - WSJ.com (subscribe)

Explore : Health

Millennium shareholder sues over Takeda takeover (Japan Times)

Thu, 17 Apr 2008 22:31:55 GMT

NEW YORK (Kyodo) A shareholder of U.S. biotechnology-based drugmaker Millennium Pharmaceuticals Inc. has sued the company over plans by Takeda Pharmaceutical Co. to conduct a tender offer for Millennium shares, a Millennium official said Wednesday.

Source : Japan Times (subscribe)

Explore : Biotechnology, Cities and Towns, New York, New York City

Yahoo! News: Zacks Bull and Bear of the Day Highlights: Millennium Pharmaceuticals, Arkansas Best, Apple, Inc., Johnson Controls ... (Centre Daily Times) (mac.ro)

Mon, 14 Apr 2008 10:27:49 GMT

Zacks Equity Research highlights Millennium Pharmaceuticals (Nasdaq: MLNM) as the Bull of the Day and Arkansas Best Corporation (Nasdaq: ABFS) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Apple, Inc. (Nasdaq: AAPL), Johnson Controls (NYSE: JCI) and Telefonica (NYSE: TEF). Full analysis of all these stocks is available at [at.zacks.com]

Source : mac.ro (subscribe)

Explore : Apple Inc., Auto Parts, Computers, Technology, Transportation

Yahoo! News: Zacks Bull and Bear of the Day Highlights: Millennium Pharmaceuticals, Arkansas Best, Apple, Inc., Johnson Controls ... (Business Wire via Yahoo! Finance) (mac.ro)

Mon, 14 Apr 2008 10:00:00 GMT

CHICAGO----Zacks Equity Research highlights Millennium Pharmaceuticals as the Bull of the Day and Arkansas Best Corporation as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Apple, Inc. , Johnson Controls and Telefonica .

Source : mac.ro (subscribe)

Explore : Apple Inc., Auto Parts, Computers, Technology, Transportation

Zacks Bull and Bear of the Day Highlights: Millennium Pharmaceuticals, Arkansas Best, Apple, Inc., Johnson Controls … (Centre Daily Times) (MacMike News)

Mon, 14 Apr 2008 08:27:49 GMT

Source : MacMike News (subscribe)

Explore : Computers, NASDAQ, NYSE, Technology, Telecommunication

Zacks Bull and Bear of the Day Highlights: Millennium Pharmaceuticals, Arkansas Best, Apple, Inc., Johnson Controls … (Business Wire via Yahoo! Finance) (MacMike News)

Mon, 14 Apr 2008 08:00:00 GMT

CHICAGO—-Zacks Equity Research highlights Millennium Pharmaceuticals as the Bull of the Day and Arkansas Best Corporation as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Apple, Inc. , Johnson Controls and Telefonica . Original post by Yahoo! News Search Results for apple computer and software by Elliott Back

Source : MacMike News (subscribe)

Explore : Apple Inc., Computers, Technology, Telecommunication, Transportation

BeaconEquity.com - Millennium Pharmaceuticals Inc. (MLNM) Shares Climb 49 percent on $8.8 Billion Acquisition by Takeda (The Earth Times Online Newspaper)

Sat, 12 Apr 2008 10:03:52 GMT

(EMAILWIRE.COM, April 11, 2008 ) BeaconEquity.com announces the publication of ‘Millennium Pharmaceuticals Inc. (MLNM) Shares Climb 49 percent on $8.8 Billion Acquisition by Takeda’ Investors can view all of the investment articles for free by vis..

Source : The Earth Times Online Newspaper (subscribe)

Explore : Drug Manufacturers, Health Industries, IMS Health Inc., Software and services, Telecommunication